lobbying_activities: 1556475

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1556475	60c4c39e-7bbc-4145-97bc-0c52718bb275	Q2	BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC	292972	BOEHRINGER INGELHEIM USA CORPORATION	2014	second_quarter	CSP	Food and Drug Administration Safety & Innovation Act (FDASIA)	HOUSE OF REPRESENTATIVES,SENATE		490000	0	0	2014-07-17T15:01:58.937000-04:00